a neurological disorder. Autochthonous transmission of ZIKV infection has been reported in Asia, Africa, Micronesia, and Latin America with increasing descriptions of travel related cases worldwide. Since the Aedes species of mosquitoes that transmit ZIKV circulate globally, there is a significant risk of ZIKV spread worldwide. Thus, ZIKV is considered as a priority pathogen with a great public health threat. The World Health Organization has estimated that as many as four million people could be infected in American countries. Currently, there is no approved therapy or vaccine against ZIKV.